![Fred T. Hadeed](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fred T.
Hadeed, has served as Chief Financial Officer of United Therapeutics since January 2000.
In November 2003, Mr. Hadeed was promoted to Executive Vice President for Business Development and Chief Financial Officer.
Prior to joining United Therapeutics, Mr. Hadeed practiced as a certified public accountant from 1989 to 2000 at KPMG LLP, where he served as a senior manager in KPMG's life sciences practice.
| Società | Posizione | Fine |
|---|---|---|
| UNITED THERAPEUTICS CORPORATION | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 1 |
|---|---|
United Therapeutics Corp.
 United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
